{"prompt": "['Amended Clinical Trial Protocol 03', '18-Oct-2019', 'EFC14153 - dupilumab', 'Version number: 1', 'Appendix B', 'Examples of Commonly Used Asthma Controller Therapies', 'Controller Group', 'Medications', 'Inhaled corticosteroids (ICS)', 'Beclomethasone dipropionate CFC', 'Beclomethasone dipropionate HFA', 'Budesonide', 'Ciclesonide', 'Fluticasone propionate', 'Mometasone furoate', 'Triamcinolone acetonide', 'Fluticasone Furoate', 'ICS/long-acting \u00df2 agonist (LABA) combination as metered-dose inhaler (MDI)', 'Fluticasone Propionate/Salmeterol', 'Fluticasone Propionate/Formoterol', 'Fluticasone Furoate/Vilanterol', 'Budesonide /Formoterol', 'Mometasone Furoate/Formoterol', 'Beclometasone Dipropionate and Formoterol', 'LABA', 'Salmeterol', 'Formoterol', 'Bambuterol', 'Clenbuterol', 'Tulobuterol', 'Vilanterol', 'Olodaterol', 'Indacaterol', 'Leukotriene receptor antagonists (LTRA) or anti-leukotrienes', 'Montelukast', 'Pranlukast', 'Zafirlukast', 'Zileuton', 'Long-acting muscarinic antagonist (LAMA)', 'Tiotropium', 'Glucopyrronium bromide', 'Aclidinium bromide', 'Umeclidinium', 'Property of the Sanofi Group - strictly confidential', 'Page 137', 'VV-CLIN-0528583 6.0']['Amended Clinical Trial Protocol 03', '18-Oct-2019', 'EFC14153 - dupilumab', 'Version number: 1', 'Controller Group', 'Medications', 'Methylxanthines', 'Aminophylline', 'Theophylline', 'Dyphylline', 'Oxtryphylline', 'Diprophylline', 'Acebrophylline', 'Bamifylline', 'Doxofylline', 'Note: This list is indicative and not exhaustive.', 'Property of the Sanofi Group - strictly confidential', 'Page 138', 'VV-CLIN-0528583 6.0']['Amended Clinical Trial Protocol 03', '18-Oct-2019', 'EFC14153 - dupilumab', 'Version number: 1', 'Appendix C List of Prohibited Live Attenuated Vaccines', 'Bacillus Calmette-Gu\u00e9rin (BCG) antituberculosis vaccine', 'Chickenpox (Varicella)', 'Intranasal influenza (FluMist-Influenza); inactive influenza vaccine delivered by injection is', 'permitted', 'Measles (Rubeola)', 'Measles-mumps-rubella (MMR) combination', 'Measles-mumps-rubella-varicella (MMRV) combination', 'Mumps', 'Oral polio (Sabin)', 'Oral typhoid', 'Rotavirus', 'Rubella', 'Smallpox (Vaccinia)', 'Varicella Zoster (shingles)', 'Yellow fever', 'This list is indicative and not exhaustive.', 'Property of the Sanofi Group - strictly confidential', 'Page 139', 'VV-CLIN-0528583 6.0']\n\n###\n\n", "completion": "END"}